Mexico Dermatology Cro Market Size & Outlook, 2023-2030

The dermatology cro market in Mexico is expected to reach a projected revenue of US$ 114.8 million by 2030. A compound annual growth rate of 6.1% is expected of Mexico dermatology cro market from 2024 to 2030.
Revenue, 2023 (US$M)
$75.8
Forecast, 2030 (US$M)
$114.8
CAGR, 2024 - 2030
6.1%
Report Coverage
Mexico

Mexico dermatology cro market highlights

  • The Mexico dermatology cro market generated a revenue of USD 75.8 million in 2023 and is expected to reach USD 114.8 million by 2030.
  • The Mexico market is expected to grow at a CAGR of 6.1% from 2024 to 2030.
  • In terms of segment, clinical was the largest revenue generating cro type in 2023.
  • Preclinical is the most lucrative cro type segment registering the fastest growth during the forecast period.


Dermatology cro market data book summary

Market revenue in 2023USD 75.8 million
Market revenue in 2030USD 114.8 million
Growth rate6.1% (CAGR from 2023 to 2030)
Largest segmentClinical
Fastest growing segmentPreclinical
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDrug Discovery, Preclinical, Clinical
Key market players worldwideIQVIA Holdings Inc, Labcorp Drug Development, Pharmaceutical Product Development, PAREXEL, Charles River Laboratories International Inc, Icon PLC, Medidata, Syneos Health, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, Wuxi AppTec Co Ltd, Medpace Holdings Inc, CTI Clinical Trial and Consulting Services, Eurofins Scientific SE


Other key industry trends

  • In terms of revenue, Mexico accounted for 1.5% of the global dermatology cro market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil dermatology cro market is projected to lead the regional market in terms of revenue in 2030.
  • Brazil is the fastest growing regional market in Latin America and is projected to reach USD 188.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Dermatology CRO Market Companies

Name Profile # Employees HQ Website

Mexico dermatology cro market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dermatology cro market will help companies and investors design strategic landscapes.


Clinical was the largest segment with a revenue share of 75.86% in 2023. Horizon Databook has segmented the Mexico dermatology cro market based on drug discovery, preclinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Mexico dermatology cro market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Mexico dermatology cro market databook

  • Our clientele includes a mix of dermatology cro market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Mexico dermatology cro market, including forecasts for subscribers. This country databook contains high-level insights into Mexico dermatology cro market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Mexico dermatology cro market report size, by cro type, 2018-2030 (US$M)

Mexico Dermatology CRO Market Share, 2023 & 2030 (US$M)

Mexico dermatology cro market report size, by cro type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more